CSIMarket
 


Beam Therapeutics Inc   (BEAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Biotechnology & Drugs
   Industry Biotechnology & Drugs
   Sector  Healthcare
 

BEAM's Free Cash Flow Growth by Quarter and Year

Beam Therapeutics Inc 's Free Cash Flow results by quarter and year




BEAM Free Cash Flow (in millions $) FY 2021 FY 2020 FY 2019 FY 2018
IV Quarter December - -24.30 -296.23 -19.90
III Quarter September - -21.21 - 229.90
II Quarter June - -22.84 111.60 56.10
I Quarter March -38.58 -27.39 0.10 41.90
FY   -38.58 -95.74 -184.53 308.00



BEAM Free Cash Flow first quarter 2021 Y/Y Growth Comment
Beam Therapeutics Inc in the first quarter recorded free cash outflow of $ -38.58 millions.

According to the results reported in the first quarter, Beam Therapeutics Inc achieved the best Free Cash Flow growth in Biotechnology & Drugs industry. While Beam Therapeutics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the first quarter.




BEAM Free Cash Flow ( Y/Y Growth %) 2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - 57.57 %
II Quarter June - - 98.93 % -96.14 %
I Quarter March - - -99.76 % -73.11 %
FY   - - - -81.66 %

Financial Statements
Beam Therapeutics Inc 's first quarter 2021 Free Cash Flow $ -38.58 millions BEAM's Income Statement
Beam Therapeutics Inc 's first quarter 2020 Free Cash Flow $ -27.39 millions Quarterly BEAM's Income Statement
New: More BEAM's historic Free Cash Flow Growth >>


BEAM Free Cash Flow (Quarter on Quarter Growth %)

2021
2020 2019 2018
IV Quarter December - - - -
III Quarter September - - - 309.8 %
II Quarter June - - 111500 % 33.89 %
I Quarter March - - - -
FY (Year on Year)   - - - -81.66 %




Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow first quarter 2021 Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2018, 2019, 2020, 2021

Beam Therapeutics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEAM's I. Quarter Q/Q Free Cash Flow Comment
I. Quarter 2021 accomplishment of -38.58 millions by Beam Therapeutics Inc look even less good considering the free cash outflow -24.30 millions in the previous quarter.

Within Biotechnology & Drugs industry Beam Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Beam Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


BEAM's I. Quarter Q/Q Free Cash Flow Comment
Recent accomplishment of -38.58 millions by Beam Therapeutics Inc come out even less good considering the free cash outflow -24.30 millions a quarter before.

Within Biotechnology & Drugs industry Beam Therapeutics Inc achieved highest sequential Free Cash Flow growth. While Beam Therapeutics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Beam Therapeutics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Mar 31 2021)
12 Months Ending
(Dec 31 2020)
12 Months Ending
(Sep 30 2020)
12 Months Ending
(Jun 30 2020)
12 Months Ending
(Mar 31 2020)
Cumulative Free Cash Flow 12 Months Ending $ -82.14 $ -79.38 $ -616.44 $ 0.00 $ 0.00
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment
Beam Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -82 millions in the Mar 31 2021 period.
The situation is detiriorating as the cumulative free cash outflow is inflating from $ -79.38 millions for the period from Dec 31 2020 to Mar 31 2020 and $ -24.3 millions for the twelve months ending in the quarter Mar 31 2020.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment
Beam Therapeutics Inc ' has realized cumulative trailing twelve months free cash outflow of $ -82 millions in the Mar 31 2021 period.
The situation is detiriorating as the cumulative free cash outflow is getting bigger from $ -79.38 millions in TTM ending quarter Dec 31 2020 and $ -24.3 millions for the twelve months ending in the quarter a year ago Cristine Navarro wrote.

Beam Therapeutics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Biotechnology & Drugs Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Biotechnology & Drugs Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
BEAM's Free Cash Flow Growth Ratio versus Biotechnology & Drugs Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for BEAM's Competitors
Free Cash Flow Growth for Beam Therapeutics Inc 's Suppliers
Free Cash Flow Growth for BEAM's Customers

You may also want to know
BEAM's Annual Growth Rates BEAM's Profitability Ratios BEAM's Asset Turnover Ratio BEAM's Dividend Growth
BEAM's Roe BEAM's Valuation Ratios BEAM's Financial Strength Ratios BEAM's Dividend Payout Ratio
BEAM's Roa BEAM's Inventory Turnover Ratio BEAM's Growth Rates BEAM's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Mar 31 2021 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Mar 31 2021
Bausch Health Companies Inc 69.73%$ 69.732 millions
Ironwood Pharmaceuticals inc 69.01%$ 69.011 millions
National Healthcare Corp62.35%$ 62.355 millions
Meridian Bioscience Inc 57.00%$ 56.996 millions
West Pharmaceutical Services Inc 55.34%$ 55.342 millions
Bio techne Corp51.34%$ 51.339 millions
Edwards Lifesciences Corporation45.17%$ 45.169 millions
Hca Healthcare Inc 44.58%$ 44.582 millions
Natus Medical Inc42.28%$ 42.282 millions
Baxter International Inc 38.60%$ 38.603 millions
Intuitive Surgical Inc 35.37%$ 35.374 millions
Diversicare Healthcare Services Inc 31.44%$ 31.437 millions
Icu Medical Inc29.86%$ 29.862 millions
Abbvie Inc 27.84%$ 27.837 millions
Ensign Group Inc26.44%$ 26.439 millions
Semler Scientific inc 23.09%$ 23.089 millions
Merit Medical Systems Inc22.06%$ 22.062 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

CLPR's Profile

Stock Price

CLPR's Financials

Business Description

Fundamentals

Charts & Quotes

CLPR's News

Suppliers

CLPR's Competitors

Customers & Markets

Economic Indicators

CLPR's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.    Copyright © 2021 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071